adding glp-1 to insulin Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology Treatment Oral GLP-1s without fasting Els PW 26010 Meals per week:10

adding glp-1 to insulin Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology Treatment Oral GLP-1s without fasting Els PW 26010 Meals per week:10

Oral GLP-1s without fasting or reduced efficacy: Delivery approach protects peptide-based drugs from stomach acid

Is inflammation improving

Els PW 26010

Meals per week:10

Such genetic predispositions could indeed limit the effectiveness of GLP-1 RAs like tirzepatide and semaglutide in patients whose OSA is primarily driven by these underlying physiological mechanisms rather than solely by excess adiposity